Literature DB >> 1957482

Studies on the use of gerbil-derived Babesia divergens antigen for diagnosis of bovine babesiosis.

J S Gray1, B Kaye.   

Abstract

Babesia divergens antigen obtained from bovine and gerbil erythrocytes was compared for the diagnosis of bovine babesiosis by the indirect immunofluorescence antibody test (IFAT) and the enzyme-linked immunosorbent assay (ELISA). Using a range of sera from the field and from experimental cattle, it was found that antigen from the two sources did not differ significantly in sensitivity or specificity. Antigen from gerbils may, therefore, be used for serological surveys of bovine babesiosis caused by B. divergens. The IFAT and ELISA were also compared and it was concluded that they are equally effective in the detection of positive samples. For small-scale surveys, the IFAT using gerbil-derived antigen is adequate, but for large surveys the ELISA is preferable.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1957482     DOI: 10.1016/0304-4017(91)90038-w

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  3 in total

1.  Longitudinal field study on bovine Babesia spp. and Anaplasma phagocytophilum infections during a grazing season in Belgium.

Authors:  Laetitia Lempereur; Maude Lebrun; Pascale Cuvelier; Géraldine Sépult; Yannick Caron; Claude Saegerman; Brian Shiels; Bertrand Losson
Journal:  Parasitol Res       Date:  2011-09-27       Impact factor: 2.289

Review 2.  Babesia divergens, a bovine blood parasite of veterinary and zoonotic importance.

Authors:  Annetta Zintl; Grace Mulcahy; Helen E Skerrett; Stuart M Taylor; Jeremy S Gray
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

3.  Detection of Babesia divergens in southern Norway by using an immunofluorescence antibody test in cow sera.

Authors:  Gunnar Hasle; Gunnar A Bjune; Dan Christensson; Knut H Røed; Anne C Whist; Hans P Leinaas
Journal:  Acta Vet Scand       Date:  2010-10-06       Impact factor: 1.695

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.